Dr. Boyd Haley, Professor Emeritus of Chemistry/Biochemistry at the University of Kentucky gave a lecture last weekend at out IAOMT conference. This is a summary of his lecture on his view of the problems associated with heavy metal toxicity and mercury exposure.
Lets compare the classic signs and symptoms found in an Alzheimer’s disease patient’s brain and how mercury affects in human brain.
- Neurofibillary tangles in the brain
- Amyloid plaque formation by secretion of beta-amyloid
- Abnormal tubulin GTP binding
- Increased tau phosphorylation
- Inhibited creatine kinase
- Inhibition of glutamine synthetase
Pathological hallmarks induced by mercury exposure.
- Neurofibillary tangles in the brain
- Amyloid plaque formation by secretion of beta-amyloid
- Abnormal tubulin GTP bonding
- Increased tau phosphorylation
- Inhibited creatine kinase
- Inhibition of glutamine synthetase
Kind of looks similar. Maybe mercury is a factor in Alzheimer’s disease.
In fact if you are born with a specific gene (Apoliporprotein E Genotype), and you are male, and you are exposed to mercury then you have a much higher risk of Alzheimer’s disease and it starting earlier in life.
Boyd Haley along with the Emeramed company developed NBMI to clean (chelate) the body and brain of heavy metals, such as mercury. They are in the process of getting FDA approval for their NBMI (Irminix) product and may have it available to the U.S. public by next year (2018).
NBMI is a stable, uncharged, lipid-soluble heavy metal chelator/anti-oxidant that enters cells and passes the blood brain barrier. It also displays very low toxicity, binds mercury into a non-toxic, non-reactive compound, and safely excesses it out of the body.
NBMI also is an extremely powerful anti-oxidant with an ORAC level of 192,400 and an HORAC score of 299,000. These extreme effective anti-oxidant levels safely fights free radicals in the body and protect you from oxidative stress. Both of which are main causes of all chronic illnesses.
Look for further announcements for NBMI availability on this website and on the manufacture’s website, www.emeramed.com.
Print